Detailed Review,Learn everything about SIINFEKL peptide

The SIINFEKL peptide, a well-characterized octameric sequence derived from chicken ovalbumin (OVA), stands as a cornerstone in fundamental immunological studies, particularly in the realm of antigen processing and presentation. This class I (Kb)-restricted peptide epitope of OVA, with the molecular formula C45H74N10O13 and a molecular weight of approximately 963.1 g/mol, has become indispensable for researchers investigating T cell responses, cancer research, and vaccine development. Its significance is underscored by its widespread use in various assays and its role in understanding complex immunological mechanisms.

One of the primary applications of the SIINFEKL peptide is in methods to monitor antigen presentation. Specifically, it serves as a model antigen for studying how MHC class I molecules present peptides to CD8+ T cells. The ovalbumin-derived peptide SIINFEKL is known to bind with high affinity to the H-2Kb molecule, a specific MHC class I allele found in certain mouse strains. This precise interaction allows researchers to track and quantify the presentation of specific antigens. For instance, the 25-D1.16 monoclonal antibody is a valuable tool as it specifically reacts with the MHC class I-SIINFEKL peptide complex, enabling the detection and localization of these complexes on antigen-presenting cells (APCs). This antibody is crucial for understanding the quantity and localization of APCs in vivo, contributing to a deeper understanding of immune responses.

The SIINFEKL peptide is routinely used to stimulate T cells in PBMCs (peripheral blood mononuclear cells) and to quantify peptide epitope specificity. Assays such as the ELISPOT assay are frequently employed to measure IFN-γ releasing effector cells after stimulation with this peptide. Furthermore, it is routinely used to stimulate ovalbumin-specific T cells and to test novel vaccine adjuvants. Its well-defined nature makes it an ideal standard for these experiments, ensuring reproducibility and comparability of results across different studies. The SIINFEKL peptide is also pivotal in the development and validation of MHC MACSimer H-2Kb Ovalbumin (SIINFEKL), mouse tetramers, which are essential for the reliable detection, characterization, and isolation of antigen-specific T cells.

Beyond its direct use in stimulating T cells, the SIINFEKL peptide is also employed in the study of secreted SIINFEKL from 85B-OVA BCG compared to cytoplasmic SIINFEKL expressed by GFP-OVA BCG. This research helps elucidate the nuances of antigen processing pathways and how the cellular location of an antigen can influence its presentation.

Variations of the SIINFEKL peptide have also been developed to probe specific aspects of T cell receptor binding and immune response modulation. For example, the OVA G4 peptide, which is a variant with the sequence SIIGFEKL, is an agonist of the SIINFEKL peptide. Similarly, the OVA-T4 Peptide (SIITFEKL) is a low-affinity variant that still exhibits binding to H-2Kb MHC. These variants allow researchers to investigate the affinity of peptide-MHC interactions and their impact on T cell activation.

The SIINFEKL peptide is derived from the Ovalbumin (OVA) protein, which is the primary protein in egg-white. While it is a common food allergen and implicated in conditions like food allergies and asthma, its peptide fragment, SIINFEKL, has been harnessed for scientific inquiry. The OVA 257-264 (SIINFEKL) sequence is a highly immunogenic peptide and serves as a benchmark for immunological research. Its role extends to investigating the MHC class I-SIINFEKL peptide complex-positive cell population, which can be identified using techniques like immunofluorescence staining.

In summary, the SIINFEKL peptide is an indispensable tool in immunology. Its well-defined structure, predictable binding to H-2Kb MHC, and its role as a standard antigen for stimulating T cell responses have made it a gold standard in immunological research. From monitoring antigen presentation and quantifying T cell activity to developing new therapeutic strategies, the SIINFEKL peptide continues to be a critical component in advancing our understanding of the immune system. The availability of high-purity OVA (257-264) peptide for H-2Kb research ensures the reliability and accuracy of experiments utilizing this vital immunological probe.